RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Nov 2010 - 5 pages - $500
Anticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the Market
Nov 2010 - 5 pages - $500
Osaka Medical Center for Cancer and Cardiovascular Diseases – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 36 pages - $500
CardioVascular BioTherapeutics, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 40 pages - $500
The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Dec 2009 - 102 pages - $3,500
Avir Green Hills Biotechnology AG – Product Pipeline Review – Q1 2011
Mar 2011 - 26 pages - $500
CardioVascular BioTherapeutics, Inc. – Product Pipeline Review – Q1 2011
May 2011 - 43 pages - $500
Phage Biotechnology Corporation – Product Pipeline Review – Q4 2010
Dec 2010 - 25 pages - $500
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Pars Roos Biotechnology Co. - Product Pipeline Review - Q4 2010
Dec 2010 - 16 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Human therapeutics del
Therapeutic target
Cardiovascular del
Anticoagulants del
Development phase
Phase II del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us